AGY is engages in the development and commercialization of central nervous system therapeutics to cure neurological diseases and disorders.
Business Model:
Revenue: $250M
Employees: 51-200
Address: 270 E Grand Ave
City: South San Francisco
State: CA
Zip: 94080
Country: US
AGY is engages in the development and commercialization of central nervous system therapeutics to cure neurological diseases and disorders.
Contact Phone:
+16506154530
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2004 | Series C | 8 | $9M |
Alta Partners Bear Stearns Health Innoventures L.P Cheng Xin Technology Development Corp GE Capital Gimv HBM Partners JAFCO Novartis Venture Fund Alta Partners Bear Stearns Health Innoventures L.P Cheng Xin Technology Development Corp GE Capital Gimv HBM Partners JAFCO Novartis Venture Fund |
5/2001 | Series B | 5 | $13M |
Alta Partners Forward Ventures JAFCO Asia Lombard Odier Novartis Venture Fund Alta Partners Forward Ventures JAFCO Asia Lombard Odier Novartis Venture Fund |
4/2004 | Series C | $9M |
HBM Partners Alta Partners Novartis Venture Fund GIMV |
7/2002 | Series C | $31.3M |
HBM Bioventures LTD. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|